Navigation Links
Building disease-beating wheat
Date:12/12/2007

Pioneered by CSIRO researchers, in collaboration with the International Maize and Wheat Improvement Center (CIMMYT) and Sydney University, the research illustrates the major genetic improvements possible without genetic modification (GM) technology.

Wheat breeders often use wild relatives of wheat as sources of novel genes in breeding new disease-resistant wheats, research team leader Dr Phil Larkin says.

Unfortunately genes from wild relatives usually come in large blocks of hundreds of genes, and often include undesirable genes. Furthermore, these blocks of genes tend to stay together, even after many generations of breeding.

The problem can be so difficult to overcome that plant breeders sometimes give up on very valuable genes because they cannot separate them from the problematic genes.

A paper published this month in the respected international journal Theoretical and Applied Genetics details how the team recombined two wild blocks of genes from two different Thinopyrum grass species a wild relative of wheat bringing together resistance genes for leaf rust and Barley Yellow Dwarf Virus (BYDV), two of the worlds most damaging wheat diseases. The recombined gene package may also carry a resistance gene against a new stem rust strain which is causing concern worldwide.

The exciting part of the new research is that we have been able to retain the useful genes but leave behind the associated undesirable genes - most notably in this case those for yellow flour colour, an important quality characteristic in wheat, Dr Larkin says.

By developing new DNA markers and by careful testing the team has produced a number of the disease resistance packages for wheat breeders, making it faster and easier to include these important disease resistance traits in future wheat varieties.

It is hoped other examples will follow and the genetic diversity available in wild species can be recruited more extensively for wheat improvement.


'/>"/>

Contact: Tony Steeper
tony.steeper@csiro.au
61-262-465-323
CSIRO Australia  
Source:Eurekalert

Related biology news :

1. Building blocks of life
2. Rebuilding the evolutionary history of HIV-1 unravels a complex loop
3. Building blocks of life formed on Mars
4. A wheat for all seasons -- and reasons
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Building disease-beating wheat
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology: